Activation of host antitumoral responses by cationic lipid/DNA complexes

被引:31
作者
Bramson, JL [1 ]
Bodner, CA [1 ]
Graham, RW [1 ]
机构
[1] Inex Pharmaceut Corp, Burnaby, BC, Canada
关键词
cationic liposome; inflammation; gene therapy;
D O I
10.1038/sj.cgt.7700143
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A model of lipoplex-induced peritonitis was used to characterize the inflammatory response to cationic lipid:DNA lipoplexes with respect to activation of host antitumoral effector mechanisms. Three different cationic lipids were used in these studies: N,N-dioleyl-N,N-dimethylammonium chloride (DODAC), N-(1-[2,3-dioleoyloxy]propyl)-N,N,N-trimethylammonium chloride (DOTAP), and N-(1-[2,3-dioleyloxy]propyl)-N,N,N-trimethylammonium chloride (DOTMA). The DODAC and DOTMA lipoplexes exhibited similar transfection properties in vitro, whereas the DOTAP lipoplexes transfected quite poorly in all cell lines tested. Intraperitoneal injection of cationic lipoplexes into immunocompetent mice resulted in a profound infiltration of inflammatory cells, secretion of interferon-gamma, and increased natural killer activity within the peritoneal cavity. Both DODAC and DOTMA lipoplexes produced similar inflammatory responses, lasting at least 5 days. The inflammation induced by DOTAP lipoplexes peaked by day 3 and resolved to near-control levels by day 5. These data indicate that although cationic lipid DNA complexes may differ in their inflammatory properties, the natural killer activation and interferon-gamma secretion that follow lipoplex administration should provide a functional adjuvant for cancer gene therapies that benefit from immunostimulation.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 29 条
[11]  
Freimark BD, 1998, J IMMUNOL, V160, P4580
[12]  
Hall SJ, 1998, CANCER RES, V58, P3221
[13]   Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/β2-microglobulin gene in patients with cancer [J].
Heo, DS ;
Yoon, SJ ;
Kim, WS ;
Lee, KH ;
Seol, JG ;
Lee, SG ;
Jung, CW ;
Cho, EK ;
Kim, CW ;
Park, MH ;
Sung, MW ;
Kim, KH ;
Bang, WJ ;
Kim, NK .
HUMAN GENE THERAPY, 1998, 9 (14) :2031-2038
[14]  
KARP SE, 1993, J IMMUNOL, V150, P896
[15]   WEHI-13VAR - A STABLE AND SENSITIVE VARIANT OF WEHI-164 CLONE-13 FIBROSARCOMA FOR TUMOR-NECROSIS-FACTOR BIOASSAY [J].
KHABAR, KSA ;
SIDDIQUI, S ;
ARMSTRONG, JA .
IMMUNOLOGY LETTERS, 1995, 46 (1-2) :107-110
[16]   Cationic lipid-mediated transfection of cells in culture requires mitotic activity [J].
Mortimer, I ;
Tam, P ;
MacLachlan, I ;
Graham, RW ;
Saravolac, EG ;
Joshi, PB .
GENE THERAPY, 1999, 6 (03) :403-411
[17]   Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice [J].
Nomura, T ;
Yasuda, K ;
Yamada, T ;
Okamoto, S ;
Mahato, RI ;
Watanabe, Y ;
Takakura, Y ;
Hashida, M .
GENE THERAPY, 1999, 6 (01) :121-129
[18]   Regulation of interferon-γ production by IL-12 and IL-18 [J].
Okamura, H ;
Kashiwamura, S ;
Tsutsui, H ;
Yoshimoto, T ;
Nakanishi, K .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :259-264
[19]  
Parker SE, 1996, CANCER GENE THER, V3, P175
[20]  
Saffran DC, 1998, CANCER GENE THER, V5, P321